<p>(A) FLT3 mutants were cultured without IL-3 for 24 hours prior to lysis. One out of three independently representative experiments is shown. (B) To illustrate the expression of the 150/130 kDa forms of FLT3 semi-quantitive analyses of western blot band intensity were performed. Depicted is the ratio of the 150 kDa to the 130 kDa FLT3 form. Values are expressed as mean +/− S.D. of three independent experiments. Ratio of 150 kDa to 130 kDa form of FLT3 was significantly different for each FLT3-TKD (p≤0.009) and each FLT3-ITD (p≤0.002) cell line, but not for FLT3-V592A and -I867S expressing cells compared to FLT3-WT expressing cells. FLT3-WT expressing cells showed a significant differnence to the groups of FLT3-WT-like mutants (p = 0.039),...
<p>A) Surface expression of R62A and R62K mutants within B*2705 (left panel) and B*2709 context (rig...
<p>(<b>A</b>) Western blot (n = 4) analysis shows overexpression of STAT3 in stably transfected HEK-...
Mutations in the receptor tyrosine kinase FLT3 are found in up to 30% of acute myelogenous leukemia ...
<p>(A) Ba/F3 cells expressing FLT3 mutations were cultured without IL-3 for 24 hours prior to lysis....
Objective(s): Mutant forms FMS-like tyrosine kinase-3 (FLT3), are reported in 25% of childhood acute...
<p>(A) Graphic illustration of FLT3 mutants with respect to biological characteristics according to ...
<p>TF1 cells were engineered with stable expression of wild-type FLT3, or different forms of mutant ...
The extracellular complex between the haematopoietic receptor Flt3 and its cytokine ligand (FL) is t...
The extracellular complex between the haematopoietic receptor Flt3 and its cytokine ligand (FL) is t...
Materials and Methods: FLT3 was expressed on factor-dependent cells (FDC-P1) using retroviral transd...
<p>(A) Immunoblot assay. Whole cell extracts from TF1 cells with stable expression of different fo...
<p>A. Construction of truncated human T1R3 mutants. All mutants were tagged with a FLAG epitope unde...
OBJECTIVE: Fms-like tyrosine kinase-3 (FLT3), a growth factor receptor normally expressed in hematop...
<p>Cells were transfected with 2 µg/well of DNA encoding FGFR3/WT, FGFR3/G346E, or FGFR3/G375C. 24 h...
<p>A. Construction of the truncated mutants of human T1R2 and T1R3. All mutants were tagged with c-M...
<p>A) Surface expression of R62A and R62K mutants within B*2705 (left panel) and B*2709 context (rig...
<p>(<b>A</b>) Western blot (n = 4) analysis shows overexpression of STAT3 in stably transfected HEK-...
Mutations in the receptor tyrosine kinase FLT3 are found in up to 30% of acute myelogenous leukemia ...
<p>(A) Ba/F3 cells expressing FLT3 mutations were cultured without IL-3 for 24 hours prior to lysis....
Objective(s): Mutant forms FMS-like tyrosine kinase-3 (FLT3), are reported in 25% of childhood acute...
<p>(A) Graphic illustration of FLT3 mutants with respect to biological characteristics according to ...
<p>TF1 cells were engineered with stable expression of wild-type FLT3, or different forms of mutant ...
The extracellular complex between the haematopoietic receptor Flt3 and its cytokine ligand (FL) is t...
The extracellular complex between the haematopoietic receptor Flt3 and its cytokine ligand (FL) is t...
Materials and Methods: FLT3 was expressed on factor-dependent cells (FDC-P1) using retroviral transd...
<p>(A) Immunoblot assay. Whole cell extracts from TF1 cells with stable expression of different fo...
<p>A. Construction of truncated human T1R3 mutants. All mutants were tagged with a FLAG epitope unde...
OBJECTIVE: Fms-like tyrosine kinase-3 (FLT3), a growth factor receptor normally expressed in hematop...
<p>Cells were transfected with 2 µg/well of DNA encoding FGFR3/WT, FGFR3/G346E, or FGFR3/G375C. 24 h...
<p>A. Construction of the truncated mutants of human T1R2 and T1R3. All mutants were tagged with c-M...
<p>A) Surface expression of R62A and R62K mutants within B*2705 (left panel) and B*2709 context (rig...
<p>(<b>A</b>) Western blot (n = 4) analysis shows overexpression of STAT3 in stably transfected HEK-...
Mutations in the receptor tyrosine kinase FLT3 are found in up to 30% of acute myelogenous leukemia ...